Lapiński TW - Search Results

1

HBV mutations associated with lamivudine therapy.

Lapiński TW, Parfieniuk-Kowerda A, Trzos A, Jaroszewicz J, Kowalczuk O, Nikliński J, Flisiak R. Lapiński TW, et al. Przegl Epidemiol. 2013;67(4):611-6, 705-8. Przegl Epidemiol. 2013. PMID: 24741905 Free article. English, Polish.

2

[Chronic HBV infection in patients with lymphoproliferative syndromes].

Łapiński TW, Jaroszewicz J, Ostapczuk A, Flisiak R. Łapiński TW, et al. Przegl Epidemiol. 2012;66(1):25-31. Przegl Epidemiol. 2012. PMID: 22708294 Free article. Review. Polish.

3

Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

Lapinski TW, Flisiak R, Jaroszewicz J, Michalewicz M, Kowalczuk O. Lapinski TW, et al. World J Gastroenterol. 2005 Jan 21;11(3):400-2. doi: 10.3748/wjg.v11.i3.400. World J Gastroenterol. 2005. PMID: 15637753 Free PMC article. Clinical Trial.

4

[Prevalence, clinical and therapeutical implications of active CMV infection in patients with chronic hepatitis C].

Lapiński TW, Kovalchuk O, Parfieniuk A, Flisiak R. Lapiński TW, et al. Przegl Epidemiol. 2009;63(2):305-9. Przegl Epidemiol. 2009. PMID: 19799266 Polish.

5

[Epidemiological and clinical characteristics of genotype 4 HCV infection in the north-east Poland].

Łapiński TW, Pawluczuk P, Flisiak R. Łapiński TW, et al. Przegl Epidemiol. 2009;63(4):501-4. Przegl Epidemiol. 2009. PMID: 20120947 Polish.

6

[HBV infection and pregnancy].

Łapiński TW, Szulzyk T, Flisiak R. Łapiński TW, et al. Przegl Epidemiol. 2010;64(4):503-7. Przegl Epidemiol. 2010. PMID: 21473065 Polish.

7

[The occurrence of HCV genotypes and single polynucleotide polymorphisms of rs12979860 among HCV infected patients in northeastern Poland].

Kozłowski P, Pogorzelska J, Łapiński TW, Kowalczuk O, Nikliński J, Flisiak R. Kozłowski P, et al. Among authors: lapinski tw. Przegl Epidemiol. 2012;66(2):335-9. Przegl Epidemiol. 2012. PMID: 23101227 Free article. Polish.

8

SNP RS12979860 related spontaneous clearance of hepatitis c virus infection in HCV/HIV-1 coinfected patients.

Lapiński TW, Pogorzelska J, Kowalczuk O, Nikliński J, Flisiak R. Lapiński TW, et al. Przegl Epidemiol. 2013;67(3):407-9, 517-9. Przegl Epidemiol. 2013. PMID: 24340551 Free article. English, Polish.

9

The importance of sCD40 and sCD40L concentration in patients with chronic HCV infection and HIV co-infection.

Lapiński TW, Pogorzelska J, Grzeszczuk A, Swiderska M, Kowalczuk O, Nikliński J, Flisiak R. Lapiński TW, et al. Przegl Epidemiol. 2014;68(1):11-5, 105-8. Przegl Epidemiol. 2014. PMID: 25004625 Free article. English, Polish.

10

Hepatitis E virus infection--a new threat for Europe.

Łapiński TW, Jaroszewicz J. Łapiński TW, et al. Przegl Epidemiol. 2016;70(1):11-4, 103-6. Przegl Epidemiol. 2016. PMID: 27344467 Free article. English, Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page